Table 2.
Clinical and obstetric characteristics of HIV-infected pregnant women.
| Patient characteristics | Frequency | Percentage (%) |
|---|---|---|
| Gravidity | ||
| Gravida 1 | 35 | 14.9 |
| Gravida 2 | 57 | 24.4 |
| ≥Gravida 3 | 142 | 60.7 |
| Parity | ||
| Nulliparity | 43 | 18.4 |
| Para 1–3 | 149 | 63.7 |
| ≥Para 4 | 42 | 17.9 |
| Gestation age | ||
| 1st trimester | 13 | 5.6 |
| 2nd trimester | 110 | 47.0 |
| 3rd trimester | 111 | 47.4 |
| Coitus per week | ||
| ≤1 | 168 | 71.8 |
| ≥2 | 66 | 28.2 |
|
| ||
| Median baseline CD4 ∗ | 264 (IQR 108–434) | |
| Baseline CD4 | ||
| ≤200 | 141 | 60.3 |
| >200 | 93 | 39.7 |
| Median current CD4 ∗ | 407.5 (IQR 291–583) | |
| Current CD4 | ||
| <200 | 21 | 9.0 |
| ≥200 | 213 | 91.0 |
| Median HAART duration (months) ∗ | 16 (IQR 5–34) | |
| Duration on HAART (months) | ||
| ≤12 | 105 | 44.9 |
| 13–24 | 41 | 17.5 |
| ≥25 | 88 | 37.6 |
| Trimethoprim-sulfamethoxazole use | ||
| Yes | 215 | 91.9 |
| No | 19 | 8.1 |
| Urinary symptoms | ||
| Yes | 27 | 11.5 |
| No | 207 | 88.5 |
∗Median with interquartile range; IQR: interquartile range; HAART: highly active antiretroviral therapy.